Allergan Sustainability Performance Reports
Allergan has been tracking sustainability performance for since 1992 and made significant progress toward improving our performance. Below is a summary of five key sustainability performance indicators. Details on additional indicators are included in our Allergan Sustainability Performance Report.
Safety Performance Trend
Allergan continues our top quartile safety performance as measured by the number of injuries/illness requiring treatment beyond first aid. In 2014, we achieved an incident rate of 0.50 incidents per 100 employees. This is Allergan’s lowest incident rate on record. We also managed the number of more severe incidents as measured by the number of incidents requiring days away from work.
Climate Change and GHG Trends
The 2014 overall GHG profile for Allergan are presented in the following figures. Scope 1 GHG emissions refer to the direct GHG emissions resulting primarily from combustion processes. Scope 2 GHG emissions refer to GHG emissions resulting primarily from the consumption of purchased electricity. In 2014, our absolute GHG emissions increased by 4% vs. 2010 with an increase in sales and production. Allergan reduced GHG emissions from R&D and manufacturing operations by nearly 10% normalized to sales in 2014 versus 2013.
Energy Consumption Trend
In 2014 versus 2013, energy consumption increased by 3% on an absolute basis. On a per sales basis, the energy consumption has decreased by 10%. Allergan has used tools such as Lean 6 Sigma, DMAIC, metering and sub-metering, and Energy Star performance indicators to ensure that energy efficiency is maintained. Recent acquisitions and existing facility expansions have provided further energy efficiency opportunities.
Waste Generation Performance Trend
On an absolute basis, hazardous waste decreased by 33% in 2014 vs. 2010 even with increasing production rates. Normalized for sales, Allergan reduced hazardous waste generated by 54% in 2014 compared to 2013. Allergan realized a 26% decrease in nonhazardous waste sent for disposal in 2014 vs. 2013. The waste generated per sales units decreased by 36% in 2014 vs. 2013. Allergan has set aggressive targets of 15% hazardous and nonhazardous waste reduction based on 2010 levels to be achieved by 2015.
Allergan increased its recycling rate from 29% in 1995 to 83% in 2014. The goal in 2014 was to maintain the recycling rate at 75% or greater which is the target for the strategic plan expected to be reached by 2015. Notable recycling rate improvements occurred at Allergan Medical Pringy France, Heredia Costa Rica and Allergan Medical Santa Barbara. Allergan Brazil and Allergan Pharmaceuticals Westport and Waco are still leading with the highest recycling rates. Allergan Westport and Allergan Pringy accomplished recycling 100% of their nonhazardous waste at the end of 2013. The absolute quantity of recycled materials was 4,480 tonnes in 2014.